Case Reports
doi: 10.1097/00003072-200108000-00003.
Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease)
Affiliations
- PMID: 11452173
- DOI: 10.1097/00003072-200108000-00003
Item in Clipboard
Case Reports
Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease)
Clin Nucl Med.
2001 Aug.
Abstract
A 27-year-old woman with progressive diaphyseal dysplasia (Camurati-Engelmann disease) received pamidronate and corticosteroid therapy for bone pain. During therapy, disease activity was assessed serially using bone scintigraphy with Tc-99m HMDP. With pamidronate administration, the bone pain became worse and diaphyseal uptake of Tc-99m HMDP increased, whereas corticosteroid administration improved the bone pain and reduced the diaphyseal uptake. In this case, pamidronate and corticosteroid produced different effects. Bone scintigraphy allowed an objective assessment of the response to these treatments, accurately reflecting clinical symptoms.
Similar articles
-
Progressive diaphyseal dysplasia (Camurati-Engelmann's disease). Improvement of clinical signs and of bone scintigraphy during pregnancy.Clin Nucl Med. 1994 Feb;19(2):104-7. doi: 10.1097/00003072-199402000-00005. Clin Nucl Med. 1994. PMID: 8187392
-
Clinical and scintigraphic evaluation of corticosteroid treatment in a case of progressive diaphyseal dysplasia.J Rheumatol. 1985 Aug;12(4):809-13. J Rheumatol. 1985. PMID: 4057207
-
Scintigraphic findings in progressive diaphyseal dysplasia.J Nucl Med. 1982 Apr;23(4):324-5. J Nucl Med. 1982. PMID: 6461731
-
Treatment of Ribbing disease with 5-year follow-up and literature review.Osteoporos Int. 2017 Apr;28(4):1499-1502. doi: 10.1007/s00198-016-3896-9. Epub 2017 Jan 18. Osteoporos Int. 2017. PMID: 28101629 Review.
-
Failure of conventional treatment and losartan in Camurati-Engelmann disease: A case report.Joint Bone Spine. 2018 Oct;85(5):649-650. doi: 10.1016/j.jbspin.2018.01.015. Epub 2018 Feb 13. Joint Bone Spine. 2018. PMID: 29452301 Review. No abstract available.
Cited by
-
Multiple diaphyseal sclerosis (Ribbing disease): what about neridronate?Osteoporos Int. 2016 Oct;27(10):3127-31. doi: 10.1007/s00198-016-3604-9. Epub 2016 Apr 22. Osteoporos Int. 2016. PMID: 27105644
-
Clinical characteristics and identification of a novel TGFB1 variant in three unrelated Chinese families with Camurati-Engelmann disease.Mol Genet Genomic Med. 2022 May;10(5):e1922. doi: 10.1002/mgg3.1922. Epub 2022 Mar 21. Mol Genet Genomic Med. 2022. PMID: 35315241 Free PMC article.
-
Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.J Biomed Biotechnol. 2010;2010:686457. doi: 10.1155/2010/686457. Epub 2010 May 24. J Biomed Biotechnol. 2010. PMID: 20508815 Free PMC article.
-
Camurati-Engelmann disease: failure of response to bisphosphonates: report of two cases.Clin Rheumatol. 2005 Aug;24(4):398-401. doi: 10.1007/s10067-004-1056-7. Epub 2005 Jan 20. Clin Rheumatol. 2005. PMID: 15660289
-
Tc99m-MDP bone scintigraphy in Engelmann-Camurati disease.Indian J Nucl Med. 2011 Jan;26(1):44-5. doi: 10.4103/0972-3919.84615. Indian J Nucl Med. 2011. PMID: 21969782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
